Over 230 patients screened and over 160 patients enrolled in BriaCell’s pivotal Phase 3 study in metastatic breast cancer (MBC)Enrollment exceeding expectations with strong clinical site and patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback